die('
Site is under construction
Dear site users
Site is under construction.
The site will be ready in less than 24 hours.
We are sorry for the inconvenience.
www.yektaweb.com
');
Reports of Biochemistry and Molecular Biology
rbmb.net
Basic Sciences
http://rbmb.net
1
admin
2322-3480
2322-3480
10.61882/rbmb
en
jalali
1396
7
1
gregorian
2017
10
1
6
1
online
1
fulltext
en
Cloning and Expression of Recombinant Human Interleukin-7 in Chinese Hamster Ovary (CHO) Cells
تخصصي
Special
مقالات اصلی
Original Article
<p style="text-align: justify;"><strong><em>Background:</em></strong> The critical role of interleukin-7 (IL-7) in homeostatic proliferation and T cell survival has made it a promising cytokine for the treatment of various clinical conditions, especially those associated with lymphopenia.</p>
<p style="text-align: justify;"><strong><em>Methods:</em></strong> In the present study we expressed recombinant human interleukin-7 (rhIL-7) in Chinese hamster ovary<strong> (</strong>CHO)-K1 cells. CHO-K1 cells were stably transfected with both circular and linear forms of the pBud-h<em>IL-7 </em>recombinant by electroporation. Expression of rhIL-7 in CHO-K1 cells was confirmed by enzyme-linked immunosorbent assay (ELISA) and dot and western blots.</p>
<p style="text-align: justify;"><strong><em>Results:</em></strong> On western blots of transformed cells, a single 25 kDa band was observed, consistent with the expected molecular weight of glycosylated hIL-7. No significant expression difference was observed between cells transfected with circular or linear plasmids.</p>
<p style="text-align: justify;"><strong><em>Conclusions:</em></strong> We established a stable CHO-K1 cell line expressing rhIL-7, which we consider to be a promising system for the production of rhIL-7 as a biopharmaceutical.</p>
CHO cells, Interleukin-7, Post-translational modifications, Stable transfection.
66
73
http://rbmb.net/browse.php?a_code=A-10-1-85&slc_lang=en&sid=1
Fatemeh Sadat
Toghraie
10031947532846002237
10031947532846002237
No
Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical science, Shiraz, Iran.
Seyedeh Masoumeh
Sharifzadeh
10031947532846002238
10031947532846002238
No
Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical science, Shiraz, Iran - Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Amin
Ramezani
10031947532846002239
10031947532846002239
No
Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical science, Shiraz, Iran - Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
Elham
Mahmoudi Maymand
10031947532846002240
10031947532846002240
No
Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical science, Shiraz, Iran.
Mahsa
Yazdanpanah-Samani
10031947532846002241
10031947532846002241
No
Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical science, Shiraz, Iran.
Abbas
Ghaderi
ghaderia@sums.ac.ir
10031947532846002242
10031947532846002242
Yes
Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical science, Shiraz, Iran - Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.